Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems
- PMID: 30681938
- PMCID: PMC6658358
- DOI: 10.1080/08897077.2018.1545727
Psychiatric comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and other drug treatment initiation and engagement across 7 health care systems
Abstract
Background: Psychiatric comorbidity is common among patients with alcohol and other drug (AOD) use disorders. To better understand how psychiatric comorbidity influences AOD treatment access in health care systems, the present study examined treatment initiation and engagement among a large, diverse sample of patients with comorbid psychiatric and AOD use disorders. Methods: This study utilized data from a multisite observational study examining Healthcare Effectiveness Data and Information Set (HEDIS) measures of initiation and engagement in treatment (IET) among patients with AOD use disorders from 7 health care systems. Participants were aged 18 or older with at least 1 AOD index diagnosis between October 1, 2014, and August 15, 2015. Data elements extracted from electronic health records and insurance claims data included patient demographic characteristics, ICD-9 (International Classification of Diseases, Ninth Revision) diagnostic codes, and procedure codes. Descriptive analyses and multivariate logistic regression models were used to examine the relationship between patient-level factors and IET measures. Results: Across health care systems, out of a total of 86,565 patients who had at least 1 AOD index diagnosis during the study period, 66.2% (n = 57,335) patients also had a comorbid psychiatric disorder. Among patients with a comorbid psychiatric disorder, 34.9% (n = 19,998) initiated AOD treatment, and of those, 10.3% (n = 2,060) engaged in treatment. After adjusting for age, sex, and race/ethnicity, patients with comorbid psychiatric disorders were more likely to initiate (odds ratio [OR] = 3.20, 95% confidence interval [CI] = 3.08, 3.32) but no more likely to engage (OR = 0.56, 95% CI = 0.51, 0.61) in AOD treatment, compared with those without a comorbid psychiatric disorder. Conclusions: Findings suggest that identification of comorbid psychiatric disorders may increase initiation in AOD treatment. However, innovative efforts are needed to enhance treatment engagement both generally and especially for individuals without diagnosed psychiatric conditions.
Keywords: Comorbidity; health services research; mental health; quality indicators; substance-related disorders; treatment.
Similar articles
-
The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.Subst Abus. 2019;40(3):268-277. doi: 10.1080/08897077.2018.1544964. Epub 2019 Jan 18. Subst Abus. 2019. PMID: 30657438 Free PMC article.
-
The association between medical comorbidity and Healthcare Effectiveness Data and Information Set (HEDIS) measures of treatment initiation and engagement for alcohol and other drug use disorders.Subst Abus. 2019;40(3):292-301. doi: 10.1080/08897077.2018.1545726. Epub 2019 Jan 24. Subst Abus. 2019. PMID: 30676892 Free PMC article.
-
Healthcare Effectiveness Data and Information Set (HEDIS) measures of alcohol and drug treatment initiation and engagement among people living with the human immunodeficiency virus (HIV) and patients without an HIV diagnosis.Subst Abus. 2019;40(3):302-310. doi: 10.1080/08897077.2019.1580239. Epub 2019 Mar 25. Subst Abus. 2019. PMID: 30908174 Free PMC article.
-
Psychiatric co-morbidity and substance use disorders: treatment in parallel systems or in one integrated system?Subst Use Misuse. 2012 Jun-Jul;47(8-9):1005-14. doi: 10.3109/10826084.2012.663296. Subst Use Misuse. 2012. PMID: 22676568 Review.
-
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.Health Technol Assess. 2001;5(21):1-75. doi: 10.3310/hta5210. Health Technol Assess. 2001. PMID: 11532238 Review.
Cited by
-
Understanding the role of financial capacity in the delivery of opioid use disorder treatment.BMC Health Serv Res. 2023 Feb 16;23(1):166. doi: 10.1186/s12913-023-09179-z. BMC Health Serv Res. 2023. PMID: 36797752 Free PMC article.
-
Lessons learned and future directions: A scoping review of American Indian and Alaska Native participants in the National Drug Abuse Treatment Clinical Trials Network.J Subst Use Addict Treat. 2023 Oct;153:209081. doi: 10.1016/j.josat.2023.209081. Epub 2023 May 23. J Subst Use Addict Treat. 2023. PMID: 37230391 Free PMC article.
-
A scoping review of healthcare effectiveness data and information set (HEDIS) substance use disorder measures.Ann Med. 2025 Dec;57(1):2447413. doi: 10.1080/07853890.2024.2447413. Epub 2025 Jan 2. Ann Med. 2025. PMID: 39745202 Free PMC article.
-
Impact of Cluster B Personality Disorders in Drugs Therapeutic Community Treatment Outcomes: A Study Based on Real World Data.J Clin Med. 2021 Jun 10;10(12):2572. doi: 10.3390/jcm10122572. J Clin Med. 2021. PMID: 34200750 Free PMC article.
References
-
- Center for Behavioral Health Statistics and Quality. 2015 National Survey on Drug Use and Health: Detailed Tables Rockville, MD: Substance Abuse and Mental Health Services Administration; 2016.
-
- Wu LT, Ringwalt CL and Williams CE. Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatr Serv 2003;54(3):363–369. - PubMed
-
- Harris KM and Edlund MJ. Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatr Serv 2005;56(8):954–959. - PubMed